Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Butyrolactone 3

Copy Product Info
😃Good
Catalog No. T14839Cas No. 778649-18-6
Alias MB-3, MB3, MB 3

Butyrolactone 3 (MB-3) is a histone acetyltransferase Gcn5 inhibitor with a weak affinity for CBP.Butyrolactone 3 has antimicrobial activity and has been used in cancer, metabolic and neurological disorders.

Butyrolactone 3

Butyrolactone 3

Copy Product Info
😃Good
Purity: 99.5%
Catalog No. T14839Alias MB-3, MB3, MB 3Cas No. 778649-18-6
Butyrolactone 3 (MB-3) is a histone acetyltransferase Gcn5 inhibitor with a weak affinity for CBP.Butyrolactone 3 has antimicrobial activity and has been used in cancer, metabolic and neurological disorders.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$67In StockIn Stock
5 mg$153In StockIn Stock
10 mg$247In StockIn Stock
25 mg$496In StockIn Stock
50 mg$828In StockIn Stock
100 mg$1,090-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.5%
Appearance:Solid
Color:White to Pink
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Butyrolactone 3 (MB-3) is a histone acetyltransferase Gcn5 inhibitor with a weak affinity for CBP.Butyrolactone 3 has antimicrobial activity and has been used in cancer, metabolic and neurological disorders.
Targets&IC50
GCN5:100 μM
In vitro
Butyrolactone 3 (50, 100, 200 μM; 16 h; RCH-ACV cells) can reduce Gcn5 acetylation and induces E2A-PBX1 degradation. Butyrolactone 3 decreased the protein levels of E2A-PBX1 and E2A in a dose-dependent manner, and reduced Wnt16 and GCN5 protein levels.[3]
SynonymsMB-3, MB3, MB 3
Chemical Properties
Molecular Weight184.19
FormulaC9H12O4
Cas No.778649-18-6
SmilesCCC[C@H]1OC(=O)C(=C)[C@@H]1C(O)=O
Relative Density.1.31g/cm3
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 150 mg/mL (814.38 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (17.92 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM5.4292 mL27.1459 mL54.2918 mL271.4588 mL
5 mM1.0858 mL5.4292 mL10.8584 mL54.2918 mL
10 mM0.5429 mL2.7146 mL5.4292 mL27.1459 mL
20 mM0.2715 mL1.3573 mL2.7146 mL13.5729 mL
50 mM0.1086 mL0.5429 mL1.0858 mL5.4292 mL
100 mM0.0543 mL0.2715 mL0.5429 mL2.7146 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Butyrolactone 3 | purchase Butyrolactone 3 | Butyrolactone 3 cost | order Butyrolactone 3 | Butyrolactone 3 chemical structure | Butyrolactone 3 in vitro | Butyrolactone 3 formula | Butyrolactone 3 molecular weight